Fair Isaac (FICO)
(Delayed Data from NYSE)
$1,988.91 USD
-4.20 (-0.21%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $1,988.46 -0.45 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1,988.91 USD
-4.20 (-0.21%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $1,988.46 -0.45 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Zacks News
ASGN vs. FICO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ASGN vs. FICO: Which Stock Is the Better Value Option?
Fair Isaac (FICO) Misses Q4 Earnings Estimates
by Zacks Equity Research
Fair Isaac (FICO) delivered earnings and revenue surprises of -5.97% and 3.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
SAIC or FICO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SAIC vs. FICO: Which Stock Is the Better Value Option?
SAIC vs. FICO: Which Stock Is the Better Value Option?
by Zacks Equity Research
SAIC vs. FICO: Which Stock Is the Better Value Option?
ASGN or FICO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ASGN vs. FICO: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
by Zacks Equity Research
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
4 Top Stocks to Buy on Blockbuster Earnings Growth
by Tirthankar Chakraborty
We shortlist four solid stocks that have striking earnings growth and positive estimate revisions.
DOX vs. FICO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOX vs. FICO: Which Stock Is the Better Value Option?
Amdocs Collaborates With Amazon Web for AmdocsONE Launch
by Zacks Equity Research
Amdocs Limited (DOX) forms a strategic collaboration with Amazon Web Services to develop solutions that would help the service providers to better adapt to the digital world in a cost-effective way.
7 GARP Stocks That Should Find a Place in Your Portfolio
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Unisys (UIS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Unisys Corporation's (UIS) Q4 earnings gain from healthy top-line growth and a moderate decline in operating expenses.
ServiceNow (NOW) Q4 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
ServiceNow (NOW) reports fourth-quarter 2017 results, beating estimates on wide scale product adoption.
5 Stocks to Buy on the Dip
by David Bartosiak
If you liked these stocks yesterday, you'll love them today after the market has provided a great buying opportunity.
Infosys (INFY) BPO Subsidiary Secures Consent to Change Name
by Zacks Equity Research
Infosys Limited's (INFY) Business Process Outsourcing subsidiary, Infosys BPO, changes name to Infosys BPM Limited. The modification is in sync with the shift in its service-providing approach.
Unisys (UIS) to Offer Cloud Services for Record Management
by Zacks Equity Research
Unisys (UIS) has consistently collaborated with the federal government to enhance the security features of its various websites and reduce operating costs.
Falling Earnings Estimates Signal Weakness Ahead for Cogint (COGT)
by Zacks Equity Research
It seems to be a wise decision for investors to drop Cogint (COGT) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
Science Applications (SAIC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Science Applications' (SAIC) third-quarter fiscal 2018 results benefit from higher revenues on new contracts supporting NASA, the U.S. Army and EPA.
Nutanix's (NTNX) Q1 Loss Narrower Than Expected, Stock Up
by Zacks Equity Research
Nutanix's (NTNX) first-quarter fiscal 2018 earnings benefit from expanding customer base, strong billings and lower operating expenses.
The Zacks Analyst Blog Highlights: Bruker, Dana, Fair Isaac, Skechers and SodaStream
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bruker, Dana, Fair Isaac, Skechers and SodaStream
5 Strong Buy Stocks Gaining Momentum
by David Bartosiak
These five strong buy stocks are at highs and still gaining momentum
Zacks.com highlights: Fair Isaac, Home Depot, Primerica and Broadridge Financial Solutions
by Zacks Equity Research
Zacks.com highlights: Fair Isaac, Home Depot, Primerica and Broadridge Financial Solutions
CDK Global (CDK) Catches Eye: Stock Jumps 5.1%
by Zacks Equity Research
CDK Global (CDK) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
4 GARP Stocks to Buy for Maximum Returns
by Zacks Equity Research
GARP strategy helps an investor gain exposure to stocks that are undervalued and have impressive prospects.
Microsemi (MSCC) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Microsemi's (MSCC) strong fiscal fourth-quarter 2017 results were driven by strength in data center, aerospace & defense and industrial end markets.
Zillow (ZG) Q3 Earnings Beat on Strong Marketplace Revenues
by Zacks Equity Research
Zillow (ZG) reported better-than-expected third-quarter results backed by impressive growth of Marketplace.